Board of  Directors

The CytoVeris board of Directors is a blend of individuals with exceptional backgrounds and experience in venturing, strategic exits, and medical technologies.

KEVIN
DIDDEN


Chairperson Kevin has spent the last 20 years as the Founder and CEO of CiDRA, a trusted process optimization company to many of the largest companies in the world.

ALAN
KERSEY


Alan has been involved in the innovation and commercialization of optical instrumentation and biotech tools and systems through various start-ups in Connecticut for over 25 years.

MICHAEL
GRILLO


Mike Grillo is an attorney with venture capital, corporate finance, and transactional experience.

CYNDI
GREEN


Cyndi Green leads CI investments in biotherapeutics, life sciences, medical devices and digital health.

SCOTT
FLORA


Scott Flora has over 30 years of Medical Device Experience in Implantable Devices and Surgical Instruments and Systems.

Advisory Team

We have a strong and highly experienced range of business, clinical and scientific advisors

JOSE
COSTA


Professor of Pathology and Medicine (Oncology), Yale University School of Medicine

VANCE
MOORE


Vance has more the 30 years in the healthcare supply chain business. Best practice business case development and execution.

ISHAN
BARMAN


Associate Professor, Johns Hopkins University

JOHN
MOON


VP & Distinguished scientist. Ph.D. from Brown University

MICHAEL
FENN


Director Healthcare & Life Sciences, Harvard Innovation Labs

ANOOP
MERANEY, MD


Dr. Anoop Meraney, MB BS is a Urology Specialist in Manchester, CT. Dr. Meraney has extensive experience in Urologic Surgery and Urinary Conditions.

SHELDON
FELDMAN, MD


Chief, Division of Breast Surgery & Breast Surgical Oncology Director at the Montefiore M-E Center for Cancer Care

NIAMEY WILSON, MD, FACS


Associate Director, Breast Program, Hartford HealthCare Cancer Institute Breast Surgery Division Leader Hartford HealthCare

Join us and be a part of our success.

At CytoVeris, we are looking for individuals interested in shaping the future of surgery through innovative AI-powered imaging solutions. 

Investor Login